Skip to main content

Table 2 Pre and post IPSS

From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia

Variables

Median (mean±SD)

P value

Pre

Post

Q1

1 (1.9 ± 2.0)

1 (1.6 ± 1.7)

0.631

Q2

3 (2.8 ± 1.4)

2 (2.3 ± 1.3)

0.263

Q3

1 (1.9 ± 2.1)

1 (1.3 ± 1.3)

0.603

Q4

2 (1.8 ± 1.6)

1 (1.6 ± 1.5)

0.227

Q5

1 (1.6 ± 1.6)

1 (2.2 ± 1.9)

0.598

Q6

0 (1.1 ± 1.5)

1 (1.2 ± 1.6)

0.756

Q7

3 (2.9 ± 0.7)

2 (2.4 ± 1.0)

0.033*

total score (Q1-7)

15 (15.0 ± 7.9)

11 (12.6 ± 6.0)

0.142

QOL

5 (4.4 ± 1.5)

4 (3.8 ± 1.5)

0.206

  1. *; p < 0.05.